BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31622620)

  • 41. How to Ensure Patient Adherence to Colorectal Cancer Screening and Surveillance in Your Practice.
    Hassan C; Kaminski MF; Repici A
    Gastroenterology; 2018 Aug; 155(2):252-257. PubMed ID: 29964039
    [No Abstract]   [Full Text] [Related]  

  • 42. The time has arrived for national reimbursement of screening CT colonography.
    Yee J; Keysor KJ; Kim DH
    AJR Am J Roentgenol; 2013 Jul; 201(1):73-9. PubMed ID: 23789660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cost-effectiveness analysis on colorectal cancer screening program].
    Huang QC; Ye D; Jiang XY; Li QL; Yao KY; Wang JB; Jin MJ; Chen K
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):65-68. PubMed ID: 28100379
    [No Abstract]   [Full Text] [Related]  

  • 44. Colorectal Cancer: Advances in Prevention and Early Detection.
    Miles A; van Duijnhoven F; McQueen A; Oliphant R
    Biomed Res Int; 2015; 2015():518068. PubMed ID: 26525015
    [No Abstract]   [Full Text] [Related]  

  • 45. Socioeconomic and healthcare use-related determinants of cervical, breast and colorectal cancer screening practice in the French West Indies.
    Menvielle G; Dugas J; Richard JB; Luce D
    Eur J Cancer Prev; 2018 May; 27(3):269-273. PubMed ID: 27824663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colorectal cancer incidence in Germany: stage-shift 6 years after implementation of a colonoscopy screening program.
    Schnoor M; Waldmann A; Eberle A; Holleczek B; Katalinic A
    Cancer Epidemiol; 2012 Oct; 36(5):417-20. PubMed ID: 22677151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial.
    Lasser KE; Murillo J; Lisboa S; Casimir AN; Valley-Shah L; Emmons KM; Fletcher RH; Ayanian JZ
    Arch Intern Med; 2011 May; 171(10):906-12. PubMed ID: 21606094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care.
    Sunkara V; Hébert JR
    Cancer; 2015 May; 121(10):1563-9. PubMed ID: 25572676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interval colorectal cancer: a challenging field in colorectal cancer.
    Dong SH; Huang JQ; Chen JS
    Future Oncol; 2018 Jun; 14(13):1307-1316. PubMed ID: 29741114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Organisation.
    Malila N; Senore C; Armaroli P;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE31-48. PubMed ID: 23012121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Data dreaming over four decades.
    Hewett P
    ANZ J Surg; 2017 Jan; 87(1-2):5-6. PubMed ID: 28156071
    [No Abstract]   [Full Text] [Related]  

  • 52. From Colorectal Cancer Screening Guidelines to Headlines: Beware!
    Bretthauer M; Kalager M; Weinberg DS
    Ann Intern Med; 2018 Sep; 169(6):405-406. PubMed ID: 29987330
    [No Abstract]   [Full Text] [Related]  

  • 53. [Methods to increase participation in cancer screening programmes].
    Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
    Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colorectal cancer screening: is earlier better?
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):519. PubMed ID: 30047441
    [No Abstract]   [Full Text] [Related]  

  • 55. Divergent understanding of health professionals regarding correct subsequent management of an asymptomatic patient with a positive faecal occult blood test and negative colonoscopy with resultant cost implications.
    Beswick L; Ting A; Macrae F; Dowling D; Hair C
    Intern Med J; 2014 Dec; 44(12a):1264-5. PubMed ID: 25442767
    [No Abstract]   [Full Text] [Related]  

  • 56. Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Economic Analysis.
    Palimaka S; Blackhouse G; Goeree R
    Ont Health Technol Assess Ser; 2015; 15(15):1-43. PubMed ID: 26366240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening.
    Steinwachs D; Allen JD; Barlow WE; Duncan RP; Egede LE; Friedman LS; Keating NL; Kim P; Lave JR; LaVeist TA; Ness RB; Optican RJ; Virnig BA
    NIH Consens State Sci Statements; 2010 Feb; 27(1):1-31. PubMed ID: 20140035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Policy of screening for colorectal cancer in Saudi Arabia: A prospective analysis.
    Aljumah AA; Aljebreen AM
    Saudi J Gastroenterol; 2017; 23(3):161-168. PubMed ID: 28611339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The association between Medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
    Resnick MJ; Graves AJ; Gambrel RJ; Thapa S; Buntin MB; Penson DF
    Cancer; 2018 Nov; 124(22):4366-4373. PubMed ID: 30412287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colorectal cancer control: providing adequate care to those who need it.
    Brawley OW
    J Natl Cancer Inst; 2014 Apr; 106(4):dju075. PubMed ID: 24681601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.